Source Bio Inc is categorized under Blood Derivative Diagnostic Agents in Temecula, CA and active since 2006.
Source Bio Inc was established in 2006, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Blood Derivative Diagnostic Agents business, which does work in the B2B market, and is classified as a Blood Derivative Diagnostic Agents, under code number by the NAICS.
If you are seeking more information, feel free to contact Duane Pinkerton at the company’s single location by writing to 43379 Business Park Drive
Suite 100, Temecula, California CA 92590 or by phoning (951) 676-1000. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Source Bio Inc |
Contact Person: | Duane Pinkerton |
Address: | 43379 Business Park Drive Suite 100, Temecula, California 92590 |
Phone Number: | (951) 676-1000 |
Website Address: | sourcebioinc.com |
Annual Revenue (USD): | $5.000.000 to $9.999.999 |
Founded: | 2006 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Blood Derivative Diagnostic Agents |
Share This Business: |
Source Bio Inc was started in 2006 to provide professional Blood Derivative Diagnostic Agents under the SIC code and NAICS code . Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.
Feel free to contact Duane Pinkerton for inquiries that concern Source Bio Inc by calling the company number (951) 676-1000, as your correspondence is most welcome.
Additionally, the physical location of the single location of Source Bio Inc can be found at the coordinates 33.49798,-117.1618 as well as the street address 43379 Business Park Drive
Suite 100 in Temecula, California 92590.
For its online presence, you may visit Source Bio Inc’s website at sourcebioinc.com and engage with its social media outlets through on Twitter and on Facebook.